Primary prevention of coronary heart disease in postmenopausal women

American Journal of Medicine

Volumn 107, Issue 2 SUPPL. 1, 1999, Pages 48-50

  Denke, Margo A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; CARDIOVASCULAR RISK; CONFERENCE PAPER; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; POSTMENOPAUSE; PRIMARY PREVENTION; PRIORITY JOURNAL; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; AGE; BLOOD; CORONARY ARTERY DISEASE; GENETICS; MIDDLE AGED; REVIEW; RISK FACTOR; CHOLESTEROL METABOLISM; CORONARY RISK; COST EFFECTIVENESS ANALYSIS; HIGH RISK POPULATION; MAJOR CLINICAL STUDY; PATIENT EDUCATION; RECEPTOR DENSITY; RISK BENEFIT ANALYSIS; SEX DIFFERENCE;

AGE FACTORS; CHOLESTEROL, LDL; CORONARY DISEASE; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERTENSION; MIDDLE AGED; POSTMENOPAUSE; PRIMARY PREVENTION; RISK FACTORS; SMOKING;

EID: 0032868910     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00149-7     Document Type: Conference Paper

References (18)

1. Downs J.R., Clearfield M., Weis S., et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels results of the AFCAPS/TexCAPS . JAMA. 279:1998;1615-1622.
2. Summary of the second report. JAMA. 269:1993;3015-3023.
3. Kannel W.B. Metabolic risk factors for coronary heart disease in women perspective from the Framingham Study . Am Heart J. 114:1987;413-419.
4. Colditz G.A., Stampfer M.J., Willett W.C., Rosner B., Speizer F.E., Hennekens C.H. A prospective study of parental history of myocardial infarction and coronary heart disease in women. Circulation. 69:1984;1065-1069.
5. Vogt M.T., Cauley J.A., Scott J.C., Kuller L.H., Browner W.S. Smoking and mortality among older women the study of osteoporotic women . Arch Intern Med. 156:1996;630-636.
6. La Croix A.Z., Lang J., Scherr P., et al. Smoking and mortality among older men and women in three communities. N Engl J Med. 324:1991;1619-1625.
7. Manson J.E., Colditz G.A., Stampfer M.J., et al. A prospective study of obesity and coronary heart disease in women. N Engl J Med. 322:1990;882-889.
8. Manolio T.A., Pearson T.A., Wenger N.K., Barrett-Conner E., Payne G.H., Harlan W.R. Cholesterol and heart disease in older persons and women review of an NHLBI workshop . Ann Epidemiol. 2:1992;161-176.
9. La Rosa J.C. Triglycerides and coronary risk in women and the elderly. Arch Intern Med. 157:1997;961-968.
10. Miller-Bass K., Newschaffer C.J., Klag M.J., Bush T.L. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med. 153:1993;2209-2216.
11. Orchard T.J. The impact of gender and general risk factors on the occurrence of atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. Ann Med. 28:1996;323-333.
12. Sowers J.R. Diabetes mellitus and cardiovascular disease in women. Arch Intern Med. 158:1998;617-621.
13. Denke M.A. Individual responsiveness to a cholesterol-lowering diet in postmenopausal women with moderate hypercholesterolemia. Arch Intern Med. 154:1994;1977-1982.
14. Denke M.A. Dietary determinants of high-density-lipoprotein cholesterol levels. Cardiovasc Risk Factors. 3:1993;4-8.
15. Stefanick M.L., Mackey S., Sheehan M., Ellsworth N., Haskell W.L., Wood P.D. Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol. N Engl J Med. 339:1998;12-20.
16. Darling G.M., Johns J.A., McCloud P.I., Davis S.R. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women. N Engl J Med. 337:1997;595-601.
17. Davidson M.H., Testolin L.M., Maki C.K., von Duvillard S., Drennan K.B. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women. Arch Intern Med. 157:1997;1186-1192.
18. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 280:1998;605-613.